DAVITA INC. Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations
DAVITA INC. (DVA) reported Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations of $198.09 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-22.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems · last filed 2023-02-22
- DAVITA INC. income tax expense (benefit), continuing operations, discontinued operations for fiscal 2022 was $198.09M, a 35.42% decline from fiscal 2021.
- DAVITA INC. income tax expense (benefit), continuing operations, discontinued operations for fiscal 2021 was $306.73M, a 2.81% decline from fiscal 2020.
- DAVITA INC. income tax expense (benefit), continuing operations, discontinued operations for fiscal 2020 was $315.59M, a 1.48% decline from fiscal 2019.
- DAVITA INC. income tax expense (benefit), continuing operations, discontinued operations for fiscal 2019 was $320.32M, a 10.57% decline from fiscal 2018.
| Period end | Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations 12 month |
|---|---|
| 2022-12-31 | $198.09M 10-K · filed 2023-02-22 |
| 2021-12-31 | $306.73M 10-K · filed 2023-02-22 |
| 2020-12-31 | $315.59M 10-K · filed 2023-02-22 |
| 2019-12-31 | $320.32M 10-K · filed 2022-02-11 |
| 2018-12-31 | $358.17M 10-K · filed 2021-02-12 |
| 2017-12-31 | -$41.00M 10-K · filed 2020-02-21 |
| 2016-12-31 | $455.81M 10-K · filed 2019-02-22 |
| 2015-12-31 | $295.73M 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |